Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

DRTSW

Alpha Tau Medical (DRTSW)

Alpha Tau Medical Ltd
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:DRTSW
일자시간출처헤드라인심볼기업
2024/12/1822:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
2024/12/1822:30GlobeNewswire Inc.Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update DayNASDAQ:DRTSWAlpha Tau Medical Ltd
2024/12/1723:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
2024/12/1723:00GlobeNewswire Inc.Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as AdvisorNASDAQ:DRTSWAlpha Tau Medical Ltd
2024/12/1722:55Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
2024/12/1122:30GlobeNewswire Inc.Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:DRTSWAlpha Tau Medical Ltd
2024/12/0622:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
2024/12/0622:30GlobeNewswire Inc.Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors SymposiumNASDAQ:DRTSWAlpha Tau Medical Ltd
2024/11/2006:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
2024/11/2006:00GlobeNewswire Inc.Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:DRTSWAlpha Tau Medical Ltd
2024/11/1322:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
2024/11/1322:30GlobeNewswire Inc.Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare ConferenceNASDAQ:DRTSWAlpha Tau Medical Ltd
2024/10/2121:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
2024/10/2121:30GlobeNewswire Inc.Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma MultiformeNASDAQ:DRTSWAlpha Tau Medical Ltd
2024/10/1021:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
2024/10/1021:30GlobeNewswire Inc.Alpha Tau Treats First Patient with Recurrent Lung CancerNASDAQ:DRTSWAlpha Tau Medical Ltd
2024/09/2021:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
2024/09/2021:30GlobeNewswire Inc.Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCCNASDAQ:DRTSWAlpha Tau Medical Ltd
2024/08/2221:30GlobeNewswire Inc.Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor ConNASDAQ:DRTSWAlpha Tau Medical Ltd
2024/08/1505:02GlobeNewswire Inc.Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:DRTSWAlpha Tau Medical Ltd
2024/06/2521:30GlobeNewswire Inc.Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial CancersNASDAQ:DRTSWAlpha Tau Medical Ltd
2024/05/2121:47Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
2024/05/2121:45GlobeNewswire Inc.Alpha Tau to Present at the Jefferies Global Healthcare ConferenceNASDAQ:DRTSWAlpha Tau Medical Ltd
2024/05/2105:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
2024/05/2105:01GlobeNewswire Inc.Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:DRTSWAlpha Tau Medical Ltd
2024/05/1405:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
2024/05/1321:30GlobeNewswire Inc.Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal CancerNASDAQ:DRTSWAlpha Tau Medical Ltd
2024/05/0621:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
2024/05/0621:30GlobeNewswire Inc.Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in GlasgowNASDAQ:DRTSWAlpha Tau Medical Ltd
2024/05/0121:30GlobeNewswire Inc.Alpha Tau to Participate in May Investor ConferencesNASDAQ:DRTSWAlpha Tau Medical Ltd
 검색 관련기사 보기:NASDAQ:DRTSW